Page 41 - manuscript_ijb05590
P. 41

105. Wei W, Sun J, Guo XY, et al. Microfluidic-based holonomic constraints of siRNA
                        in the kernel of lipid/polymer hybrid nanoassemblies for improving stable and safe
                        In  vivo  delivery.  ACS  Appl  Mater  Interfaces.  2020;12(13):14839-14854.
                        doi:10.1021/acsami.9b22781

                   106. Balachandran YL, Li X, Jiang X. Integrated microfluidic synthesis of aptamer
                        functionalized  biozeolitic  imidazolate  framework  (BioZIF-8)  targeting  lymph
                        node       and       tumor.      Nano        Lett.      2021;21(3):1335-1344.
                        doi:10.1021/acs.nanolett.0c04053


                   107. Yan J, Xu X, Zhou J, et al. Fabrication of a pH/redox-triggered mesoporous silica-
                        based  nanoparticle  with  microfluidics  for  anticancer  drugs  doxorubicin  and
                        paclitaxel   codelivery.   ACS   Appl    Bio   Mater.    2020;3(2):1216-1225.
                        doi:10.1021/acsabm.9b01111

                   108. Han  X,  Zhang  G, Wu  X,  et  al.  Microfluidics-enabled  fluorinated  assembly  of
                        EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t
                        cells regulation in cancer immunotherapy. J Nanobiotechnology. 2024;22(1):90.
                        doi:10.1186/s12951-024-02328-4

                   109. Zhang  Q,  Wang  X,  Kuang  G,  Yu  Y,  Zhao  Y.  Photopolymerized  3D  printing
                        scaffolds with Pt(IV) prodrug initiator for postsurgical tumor treatment. Res Wash
                        DC. 2022;2022:9784510. doi:10.34133/2022/9784510


                   110. Li J, Zhu T, Jiang Y, Zhang Q, Zu Y, Shen X. Microfluidic printed 3D bioactive
                        scaffolds  for  postoperative  treatment  of  gastric  cancer.  Mater  Today  Bio.
                        2024;24:100911. doi:10.1016/j.mtbio.2023.100911

                   111. Xu Y, Zhu S, Xia C, et al. Liquid biopsy-based multi-cancer early detection: an
                        exploration road from evidence to implementation. Sci Bull. Published online June
                        24, 2025. doi:10.1016/j.scib.2025.06.030

                   112. Sun H, Yao X, Jiao Y, et al. DNA remnants in red blood cells enable early detection
                        of  cancer.  Cell  Res.  Published  online  May  9,  2025.  doi:10.1038/s41422-025-
                        01122-7


                   113. Abusara  OH, Agha ASAA,  Bardaweel  SK. Advancements  and  innovations  in
                        liquid  biopsy  through  microfluidic  technology  for  cancer  diagnosis.  Analyst.
                        2025;150(9):1711-1725. doi:10.1039/d5an00105f

                   114. Xie Y, Xu X, Wang J, Lin J, Ren Y, Wu A. Latest advances and perspectives of
                        liquid biopsy for cancer diagnostics driven by microfluidic on-chip assays. Lab
                        Chip. 2023;23(13):2922-2941. doi:10.1039/d2lc00837h

                   115. Marassi  V,  Giordani  S,  Placci  A,  et  al.  Emerging  microfluidic  tools  for
                        simultaneous exosomes  and cargo biosensing  in liquid  biopsy:  new integrated


                                                            40
   36   37   38   39   40   41   42   43   44   45   46